Bakker MK - Search Results

1

Selection of controls in case-control studies on maternal medication use and risk of birth defects.

Bakker MK, de Walle HE, Dequito A, van den Berg PB, de Jong-van den Berg LT. Bakker MK, et al. Birth Defects Res A Clin Mol Teratol. 2007 Sep;79(9):652-6. doi: 10.1002/bdra.20388. Birth Defects Res A Clin Mol Teratol. 2007. PMID: 17668455

2

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT. Bakker MK, et al. Br J Clin Pharmacol. 2008 Apr;65(4):600-6. doi: 10.1111/j.1365-2125.2007.03048.x. Epub 2007 Oct 22. Br J Clin Pharmacol. 2008. PMID: 17953715 Free PMC article.

3

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT. Bakker MK, et al. Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):94-100. doi: 10.1002/bdra.20641. Birth Defects Res A Clin Mol Teratol. 2010. PMID: 19937603

4

Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands.

van Beynum IM, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HE. van Beynum IM, et al. Among authors: bakker mk. Eur Heart J. 2010 Feb;31(4):464-71. doi: 10.1093/eurheartj/ehp479. Epub 2009 Dec 1. Eur Heart J. 2010. PMID: 19952004

5

Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study.

Bakker MK, De Walle HE, Wilffert B, de Jong-Van den Berg LT. Bakker MK, et al. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):808-13. doi: 10.1002/pds.1964. Pharmacoepidemiol Drug Saf. 2010. PMID: 20572024

6

Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?

Jentink J, Bakker MK, Nijenhuis CM, Wilffert B, de Jong-van den Berg LT. Jentink J, et al. Among authors: bakker mk. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):803-7. doi: 10.1002/pds.1975. Pharmacoepidemiol Drug Saf. 2010. PMID: 20680999

7

Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.

Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L; EUROCAT Antiepileptic Study Working Group. Jentink J, et al. BMJ. 2010 Dec 2;341:c6581. doi: 10.1136/bmj.c6581. BMJ. 2010. PMID: 21127116 Free PMC article. Review.

8

Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: evidence for interaction?

Baardman ME, Kerstjens-Frederikse WS, Corpeleijn E, de Walle HE, Hofstra RM, Berger RM, Bakker MK. Baardman ME, et al. Among authors: bakker mk. Heart. 2012 Mar;98(6):474-9. doi: 10.1136/heartjnl-2011-300822. Epub 2012 Jan 30. Heart. 2012. PMID: 22294555

9

Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.

van Gelder MM, van Rooij IA, de Walle HE, Roeleveld N, Bakker MK. van Gelder MM, et al. Among authors: bakker mk. Drug Saf. 2013 Jan;36(1):43-54. doi: 10.1007/s40264-012-0004-8. Drug Saf. 2013. PMID: 23315295

10

Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.

de Jonge L, Zetstra-van der Woude PA, Bos HJ, de Jong-van den Berg LT, Bakker MK. de Jonge L, et al. Among authors: bakker mk. Drug Saf. 2013 Nov;36(11):1069-78. doi: 10.1007/s40264-013-0082-2. Drug Saf. 2013. PMID: 23828658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters